ÂÜÀòÂÒÂ×

Rahul Nahar is a seasoned researcher with extensive experience in translational research and genomics, currently serving as a Translational Research Scientist at Immuneel Therapeutics Private Limited since June 2022, where responsibilities include leading CAR-T clinical trial activities and managing clinical samples. Previously, Rahul worked as an Associate Principal Scientist at MSD, overseeing Translational Oncology/Immuno-Oncology studies across multiple regions, and as a Lead Research Associate at the Genome Institute of Singapore, focusing on whole exome-sequencing and RNA-seq in lung cancer. Early career roles included positions as a Scientist at Ocimum Biosolutions, a Postdoctoral Fellow at Childrens Hospital Los Angeles and the University of Southern California, and significant research during undergraduate studies at the Indian Institute of Technology, Kharagpur. Educational credentials include a PhD in Genetic, Molecular, and Cellular Biology from the University of Southern California and a B.Tech in Biotechnology and Biochemical Engineering from the Indian Institute of Technology, Kharagpur.